TITLE

MANAGEMENT OF LOW AND HIGH GRADE DYSPLASIA IN INFLAMMATORY BOWEL DISEASE: A GASTROENTEROLOGIST'S PERSPECTIVE AND CURRENT PRACTICE IN UK

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA98
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Colonic dysplasia is a precursor to cotorectal cancer (CRC) in inflammatory bowel disease (IBD). There is a risk of progression of low and high grade dysplasia (LGD and HGD) to CRC. A study has been conducted to get an overview of the gastroenteroloist's perspective on various aspects of colonic dysplasia in IBD and to see the current management practice in Great Britain. It has been found that there are wide variations in the perceptions and management of LGD in IBD in Great Britain compared to HGD where there seems to be a more uniform agreement.
ACCESSION #
13219197

 

Related Articles

  • Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. Fiona D M van Schaik // Gut;Feb2012, Vol. 61 Issue 2, p235 

    BACKGROUND AND AIMS: Previous studies have suggested a chemopreventive effect of 5-aminosalicylic acid (5-ASA) therapy in patients with inflammatory bowel disease (IBD). This effect has not been reported in IBD patients using thiopurines. We investigated the association between thiopurine or...

  • USE OF 5-ASA IS ASSOCIATED WITH DECREASED RISK OF DYSPLASIA AND COLON CANCER IN ULCERATIVE COLITIS.  // Gut;Apr2004 Supplement 3, Vol. 53, pA119 

    Risk factors for dysplasia and colon cancer (CRC) in ulcerative colitis (UC) include— duration and extent of disease, younger age of diagnosis, family history of CRC, and primary sclerosing cholangitis (PSC). Mesalazine (5-ASA) is a mainstay of UC treatment and has been suggested to have...

  • Colonoscopic surveillance improves survival after colorectal cancer diagnosis in inflammatory bowel disease. Lutgens, M. W. M. D.; Oldenburg, B.; Siersema, P. D.; van Bodegraven, A. A.; Dijkstra, G.; Hommes, D. W.; de Jong, D. J.; Stokkers, P. C. F.; van der Woude, C. J.; Vleggaar, F. P. // British Journal of Cancer;11/17/2009, Vol. 101 Issue 10, p1671 

    Background:Colonoscopic surveillance provides the best practical means for preventing colorectal cancer (CRC) in inflammatory bowel disease (IBD) patients. Strong evidence for improved survival from surveillance programmes is sparse.Method:The aim of this study was to compare tumour stage and...

  • Mesalamine Protects Against Colorectal Cancer in Inflammatory Bowel Disease. Tang, Jeffrey; Sharif, Omar; Chetan Pai; Silverman, Ann L. // Digestive Diseases & Sciences;Jun2010, Vol. 55 Issue 6, p1696 

    Individuals with inflammatory bowel disease (IBD) are at increased risk of developing colorectal cancer (CRC) compared with the general population. Previous studies show this risk is strongly associated with dysplasia, extent of disease, duration of disease, and degree of inflammation, while...

  • Colorectal cancer surveillance in inflammatory bowel disease: The search continues. Ahmadi, Anis; Polyak, Steven; Draganov, Peter V.; Long, Rupert // World Journal of Gastroenterology;1/7/2009, Vol. 15 Issue 1, p61 

    Patients with inflammatory bowel disease (IBD) are at increased risk for colorectal cancer (CRC). Risk factors for the development of CRC in the setting of IBD include disease duration, anatomic extent of disease, age at time of diagnosis, severity of inflammation, family history of colon...

  • Effect of adenovirus-mediated PTEN gene on ulcerative colitis-associated colorectal cancer. Li, Zhi; Liu, Gong; Liu, Yu; Chen, Xi; Huang, Xiao; Gan, Hua // International Journal of Colorectal Disease;Aug2013, Vol. 28 Issue 8, p1107 

    Purpose: This study investigated the expression pattern of PTEN and its effect on carcinogenesis of ulcerative colitis-associated colorectal cancer, leading to insights into the underlying molecular mechanism. Methods: We established a mouse model of ulcerative colitis-associated colorectal...

  • Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. van der Woude, C. J.; Moshage, H.; Homan, M.; Kleibeuker, J. H.; Jansen, P. L. M.; van Dekken, H. // Journal of Clinical Pathology;Aug2005, Vol. 58 Issue 8, p811 

    Background: Chronic ulcerative colitis (CUC) is associated with increased risk of developing colon cancer through a dysplasia (intraepithelial neoplasia)-carcinoma sequence. Aims: To investigate the expression of apoptosis and inflammatory related proteins in CUC. Methods: The expression of...

  • The management of dysplasia associated with ulcerative colitis: colectomy versus continued surveillance. Friedlich, Martin S.; Guindi, Maha; Stern, Hartley S. // Canadian Journal of Surgery;Jun2004, Vol. 47 Issue 3, p212 

    The article focuses on the management of dysplasia associated with ulcerative colitis (UC). Colectomy versus continued surveillance in patients with longstanding UC is a challenging decision. Several factors must be considered. Often such patients have quiescent disease, making the prospect of...

  • Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications. Goel, Gati A.; Kandiel, Ahmed; Achkar, Jean Paul; Lashner, Bret // American Journal of Gastroenterology;Apr2011, Vol. 106 Issue 4, p719 

    Chronic inflammatory diseases, depending upon the duration and severity, are frequently associated with an increased risk of developing cancer. A classic paradigm is the enhanced risk of colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD). Carcinogenesis is a multifactorial...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics